ArticleFrontiers in oncology2021

A Novel Prognostic Signature Based on Metabolism-Related Genes to Predict Survival and Guide Personalized Treatment for Head and Neck Squamous Carcinoma.

Ying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.